BioPorto Interim Result for the Third Quarter of 2025 – Continued progress and continued NGAL sales growth

1 month ago

November 19, 2025 Announcement no. 26 BioPorto Interim Result for the Third Quarter of 2025 – Continued progress and continued…

Aptose Biosciences Announces Arrangement Agreement for Acquisition by Hanmi Pharmaceutical

1 month ago

Aptose Biosciences minority shareholders to receive C$2.41 in cash per share in a “go private” transactionSAN DIEGO and TORONTO, Nov.…

European Commission approves Roche’s Lunsumio subcutaneous for relapsed or refractory follicular lymphoma

1 month ago

Lunsumio provides high rates of deep and long-lasting responses in third-line and later follicular lymphoma, a disease that typically becomes…

Olema Oncology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

1 month ago

SAN FRANCISCO, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical…

Protara Therapeutics to Host Conference Call and Webcast to Review New Interim Data from Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations on Wednesday, November 19, 2025

1 month ago

NEW YORK, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for…

Profound Medical Celebrates The Hong Center’s 200th Independent TULSA Procedure for Prostate Disease

1 month ago

Renowned urologist Dr. Mark Hong sets new global benchmark for urologist-led, MRI-guided prostate treatment, leading a growing movement toward incision-free…

SI-BONE To Present at Piper Sandler 37th Annual Healthcare Conference on December 2, 2025

1 month ago

SANTA CLARA, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving…

BBOT to Participate in Upcoming December Investor Healthcare Conferences

1 month ago

SOUTH SAN FRANCISCO, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical…

Solana Company Reports Third Quarter 2025 Financial Results

1 month ago

NEWTOWN, Pa., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”), a publicly listed company…

Rock Salt Marketing Launches AI SEO Services for LLM Search Visibility

1 month ago

Rock Salt Marketing Cooperative has launched new AI SEO services to help businesses improve visibility and performance across large language…